BP
Bharat Parenterals Ltd (BPLPHARMA)
₹1,770.00
Mkt cap
₹1,040 Cr
P/E ratio
—
P/B
3.78
Div yield
0.07%
ROE
−2.54%
ROCE
−1.87%
EPS (TTM)
—
Book value
₹468
52W range
46–2,278
Sector
Healthcare
Price history
Previous close
Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations [1]
NSE BPLPHARMABSE 541096
Health check
Cautious
ProfitabilityWeak
GrowthModerate
TechnicalsNeutral
52-week range
−22.29% from high₹1,770
₹46+3,739.48% from low₹2,278
Current
₹1,770.00
Prev close
₹1,772.00
Day
−0.11%
Price performance
1D
−0.11%
1W
−17.67%
1M
+16.39%
3M
—
6M
—
1Y
—
YTD
+35.42%
Financials
Revenue, profit & margin
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 69.91 | 59.81 | 59.82 | 67.82 | 92.51 | 71.63 | 72.26 | 103.98 | 116.00 | 64.62 | 65.19 | 99.62 | 93.74 | |
| Expenses | 59.46 | 55.49 | 53.21 | 66.82 | 88.02 | 79.29 | 68.62 | 101.75 | 102.22 | 63.79 | 63.45 | 100.14 | 85.21 | |
| Operating Profit | 10.45 | 4.32 | 6.61 | 1.00 | 4.49 | -7.66 | 3.64 | 2.23 | 13.78 | 0.83 | 1.74 | -0.52 | 8.53 | |
| OPM % | 14.95% | 7.22% | 11.05% | 1.47% | 4.85% | -10.69% | 5.04% | 2.14% | 11.88% | 1.28% | 2.67% | -0.52% | 9.10% | |
| Other Income | 2.10 | 2.60 | 1.26 | 2.64 | 2.54 | 4.21 | 2.94 | 1.93 | 1.06 | 3.53 | 1.33 | 3.63 | 1.11 | |
| Interest | 0.89 | 0.63 | 0.58 | 1.13 | 2.77 | 2.91 | 3.33 | 3.94 | 3.69 | 3.11 | 2.90 | 2.85 | 2.45 | |
| Depreciation | 1.58 | 1.75 | 1.82 | 3.87 | 9.03 | 9.01 | 8.76 | 8.52 | 8.60 | 8.56 | 8.46 | 8.63 | 8.69 | |
| Profit before tax | 10.08 | 4.54 | 5.47 | -1.36 | -4.77 | -15.37 | -5.51 | -8.30 | 2.55 | -7.31 | -8.29 | -8.37 | -1.50 | |
| Tax % | 30.46% | 46.48% | 33.46% | 88.24% | 85.32% | 13.92% | 43.01% | 13.61% | 133.73% | 17.65% | 16.77% | -2.51% | 138.00% | |
| Net Profit | 7.01 | 2.43 | 3.64 | -2.56 | -8.84 | -17.51 | -7.88 | -9.44 | -0.87 | -8.60 | -9.67 | -8.16 | -3.56 | |
| EPS in Rs | 13.02 | 6.05 | 6.50 | -0.52 | 1.96 | -11.50 | -2.42 | -6.86 | 11.94 | -10.49 | -6.37 | -6.96 | 1.47 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
No reaction history yet.
No quarterly filings ingested yet.
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jun 202667.20%Promoter
Promoters67.20%0.03
FIIs0.11%
DIIs1.38%0.31
Public31.31%0.34
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Bharat Parenter. | ₹1,509.70 | — | 1,040 | 0.07% | −4 | −87.73% | 94 | −19.19% | −1.87% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports15
Concall transcripts11
Announcements5
Shareholder Meeting / Postal Ballot-Scrutinizer''s Report 19 SepShareholder Meeting / Postal Ballot-Outcome of AGM 19 SepAnnouncement under Regulation 30 (LODR)-Newspaper Publication 14 Sep - Public Notice for Newspaper advertisement dated September 12, 2026.Announcement under Regulation 30 (LODR)-Newspaper Publication 28 Aug - Please find the enclosed newspaper publications intimating details of 33rd Annual General Meeting of the company schedule on September 19, 2026.Intimation Under Regulation 36 Of The SEBI (LODR) Regulations, 2015. 27 Aug - 33rd AGM scheduled for September 19, 2026; annual report and notice dispatched to shareholders.